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Abstract 
This paper reviews the contrib uti on of 
scanning electron mic roscopy (SEM) to our under-
standing of plate le t physi ol ogy and pathology. 
Observat i ons of pl atelet shape changes which 
accompany activat ion and the abi lit y to visualize 
and analyze pl atelet aggregation and adhesion in 
three dimensions make this exper imental medium 
an important tool in the evaluat ion of health y 
and diseased plat el ets. While SEM adds a 
valuable third dimension to the study of morpho-
l ogy and ultr astr uctur e, it s greatest contri-
buti on is rea li zed when st udi es are corr elated 
dir ectly with light and/or transmission el ectron 
mi croscop i c observat ions and with st udies of 
functiona l capacity. 
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Introduction 
Platelets are capabl e of activ i ties as 
diverse as those seen in nucleated cells . They 
adhere to surfaces (Hell em 1960, Michaeli and 
Orl off 1976), undergo alterations in shape (Born 
1970, White 1974b, Froj movic and Milt on 1982), 
secrete granul e contents (Whit e 1970,1973), 
interact with other platelet s to form aggregates 
(Born and Cross 1963, Vargaftig et al . 1981), 
mi grate directionally in re sponse to chemotacti c 
s i gnal s (Lowenhaupt 1982), engulf particles 
(Movat et al . 1965, Mustard and Packham 1968, 
Whit e 1972a), are capabl e of intern al contraction 
(White 1974a), and express procoagul ant activ it y 
(Walsh 1978) . 
In the maintenance of hemostasi s , adhesion, 
granul e re l ease ("the relea se reaction"), 
aggregation, and contraction are considered the 
basic plate l et reactions (White 1982). Whil e 
they usuall y occur together, any one of these 
functions can be expressed independently of the 
others. 
Adhesion refers to the interaction of plate-
lets with surfaces. Subendotheli al structures 
including collagen and microf ib ri l s provide the 
adhere nt surf aces during hemostasi s (Baumgartner 
and Haudenschild 1972). In contrast, aggrega tion 
refers to plat elet - pl at el et interactions. The 
combined effect of adhesion to subendothelial 
str uctures and platelet-platelet aggregation is 
required for the formation of a competent pr imary 
hemostatic plug (Baumgartner and Muggli 1976). 
Stimulat ion of the plate l et membrane by pl ate l et 
agonists results in mobiliz at ion of arachido nic 
acid for prostaglandin synthes i s. Thromboxane A2 (TxA?) and cyclic endoperoxide intermediates are 
powerful aggregators and stimu li for granule 
rel ease . They may act e ith er indir ect ly via 
cyclic AMP (Salzman 1977, Smith 1981) or directly 
as ionophores to mediate cal cium mobilization 
(Gerrard and White 1978) . Calciu m mobilization 
and prostaglandin (TxA?) synthesi s support cyto-
skeletal mediated internal contr act i on which is 
responsible for central migration of granules and 
microtubules following platelet stimulation and 
which contributes to the shape change associated 
with stimulation (Gerrard and White 1978) . In 
addition, contraction potentiates granule 
secretion and provides the forces for clot 
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retraction, a process that stabilizes the fibrin-
platelet network that fonns during clott ing. 
Granule secret i on enhances platelet plug for-
mation by release of ADP and serotonin, two 
powerful platelet agonists, from dense bodies 
into the immediate environment of the evolving 
aggregate, thus promoting its propagation 
(Holmsen et al. 1969). 
Functional Anatomy 
Interpretation of the three-dimensional data 
provided by SEM requires an understanding of 
platelet ultrastructure and function. White has 
introduced the concept of structural physiology 
to emphasiz e the close correlation of morphologic 
changes with physiologic and biochemical events 
in st imulat ed platelets (~/hit e 1971a). He has 
proposed subdivision of platelet anatomy into 
four functionally di stinct zones: 1) the 
peripheral zone, 2) the sol -gel zone, 3) the 
orga nell e zone and 4) the membrane systems (White 
1982). 
The peripheral zone: 
The peripheral zone is responsible for the 
plate l et's ability to recognize and respond to a 
variety of stimu li. It bears the receptor sites 
for platelet agonists and inhibitors (Berndt and 
Phillips 1981b), and it s unique composition is 
responsible for th e platelet's ability to adhere 
to other platelets and to foreign surfaces 
(Berndt and Philli ps 1981b, Nurden et al. 1981, 
Phil lip s 1980, Phillips et al. 1980, Nurden and 
Caen 1978). In addition, pl ate l et support for 
pl asma cl otting is supplied by t hi s zone which 
provides surface phospholip ids (plate l et factor 3 
or PF 3) that cata l yze several steps i n coagu-
lation (Fanti and Ward 1955, Walsh 1978). 
The peripheral zone is composed of three 
morphologic domains: ( 1) the exter i or coat or 
glycocalyx, (2) the unit membrane and (3) the 
submembranous zone. The peripheral zone extends 
into and line s the tortuous channel s of t he 
s urfa ce-co nnected open canalicular system (OCS) 
(Behnke 1967, 1970b) (Figure 1). This system of 
surface-co nnected channels gives the platelet a 
marked increase in surface area which 
Morgenstern and Stark (1975) suggest, based on 
morphometric analys i s of the OCS i n resting and 
st imulated platelets, may suppl y the membrane 
requ ire d for pseudopodia fonnation following 
platelet stimu l at i on. Milton and Frojmovic 
(1979) came to simi lar concl~sions from measure-
ments of surface area differences in resting and 
stimu lated platelets from nonnal and Bernard 
Soulier donors. In contras t, White and Clawson 
(1980) have demonstrated by freeze fracture and 
electron cytochemistry that channels of the OCS 
are seldom single channels, but rather are an 
anastamosing labyr inth of fenestrated channel s 
that could not be easily evaginated. These 
authors conclude that the OCS could not provide 
membrane for pseudopod fonnatio n. Egress of 
granule contents through the OCS has been 
demonstrated (White 1973) and engulfment of par-
ticulates occurs via thi s system (Movat et al. 
1965, White 1972a, Barnhart and Noonan 1978, 
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White and Clawson 1981, 1982). While large par-
ticle uptake does not appear to represent phago-
cytos i s (Whi te 1972a), small particle uptake is 
associated with formation of phagolysosomes and 
thus would appear to be true phagocytosis (Lewis 
et al. 1976, Whi te and Clawson 1982). 
The exterior coat or glycocalyx is formed by 
the exterior projection of membrane glycoprote i ns 
and glyco li pids. By negative stain whole mount 
electron microscopy it has been defined as a 
dense layer of 15-20 nm exterior to the trilami-
nar plasma membrane (Behnke 1967, 1968). Using 
cationic dyes, White (1971b) demonstrated that 
the platelet exterior coat is thicker and denser 
than that present in other blood cells. Despite 
its external or i entation, the exterior coat is 
not appreciated by conventiona l SEM. 
Polyacry lamide gel el ectrophoresis of isolated 
pl atelet membranes demonstrates a pattern of 
membrane glycoprote in s distinct from those of 
other blood cells (Phillips and Agin 1977, Nurden 
et al. 1981, George 1978). Of the approximate ly 
50 polypept ides identified in isolated platelet 
membranes (Sixma et al. 1982b) eight glycopro-
te in s (GP Ia, le, Ila, ls/lb, Id, Ilb, III, IV) 
are externally or i ented and can be readily 
labelled by non-penetrating radioactive probes 
(Phillips 1980, Nurden et al. 1981, Peterson 
1982). More recent l y an additiona l glycoprotein, 
GP V, has been shown to be externa ll y oriented 
(Berndt and Phillips 1981a). The external orien-
tation of these glycoproteins contribut es to the 
carbohydrate rich glycocalyx which gives the 
pl a tel et membrane its unique pr ope rt i es. Three 
of these (GP lb, Ilb, and Illa) have been impli-
cated in platelet adhesion-aggregation reactions 
and will be discussed in further deta i l under 
specific di sorders of platelet function. 
The platelet unit membrane is a trilaminar 
structure which demonstrates no differences from 
other biologic membranes by transmission electron 
microscopy (Fi gure 1). However, replicas of 
freeze fractured platelets reveal diff erences in 
the number and distribution of intercalated par-
ticles on the exoplasmi c (E) and protoplasmic (P) 
face of platelet membranes, a finding consistent 
with the differences in transmembrane protein 
composi t i on of these two membrane leaflets (White 
and Conard 1973). The plate l et membrane contains 
various enzyme systems including Na+K+ and 
ca++Mg++ ATPases (Chambers et al. 1967, White 
and Gerrard 1980) and adenylate cyclase (Haslam 
1973, Mill s and Macfarl ane 1976). 
The phospholipid or i entation in the plate l et 
membrane i s asymmetrical (Schick et al. 1976) . 
During platelet stimulation reorientation of 
membrane lipid s may provi de exposure of those 
phospholipids which confer platelet coagulant 
(PF 3) activity (Fanti and Ward 1955). 
The submembranous zone is defined as that 
membrane associated area which lies just internal 
to the plasma membrane but peripheral to the 
microtubular coil (Whit e 1982). Its composit i on 
i s not well defined but the area is thought to 
contain a regular system of filamentous elements 
(White 1969), best visualized in osmotically 
shocked plat elets (Zucker -Franklin 1970). This 
zone of dense filaments appears to exclude 
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organelles from the submembrane region. The par-
ticipation of the submembranous cytoskeleton in 
the formation of membrane-cytoskeleton lin kages 
seems likely. Debus et al. (1981) have 
demonstrated concentration of two actin modu-
lating proteins, actin binding protein and alpha-
actinin in this region as well as within 
pseudopods. Phillips et al. (1980) have 
isolated tritonized cytoskeletons from thrombin 
stimulated aggregates and by SOS gel electro-
phoresis have demonstrated the presence of 2 
membrane glycoproteins (GP IIb-IIIa) associated 
with cytoskeletons enriched in actin, actin 
binding protein, myosin, a 90K Dalton and a 56K 
Dalton protein. As compared to cytoskel etons 
from non-aggregated thrombin-stimulated platelets 
in which membrane components were no longer 
present, there was a significantly greater amount 
of actin binding protein present when membrane 
glycoproteins were linked to cytoskeletons. In 
addition the 90K and 56K components were not 
identified in nonaggregated platelets. 
Schollmeyer et al. (1978) demonstrated in vitro 
that platelet actin binding protein promotes 
actin filament crosslinking and that alpha-
act i ni n wil 1 produce lateral association of 
cross-linked actin filaments into parallel 
bundles. The presence of accessory proteins 
which promote the association of actin into 
parallel filament bundles suggests that this sub-
membranous region may be involved in pseudopod 
formation (White 1982). 
Sol-Gel Zone: 
Previously referred to as the hyaloplasm, the 
sol -gel zone i s the viscous cell matrix which 
contains proteins capable of being assembled into 
various filament systems that ~ake up the plate-
let cytoskeleton. This complex system of micro-
filaments, microtubules, and accessory/regulatory 
proteins controls cell shape and provides the 
motile forces for internal contraction and 
granule secretion. Platelet microtubules are 
involved in maintenance of the discoid shape of 
the resting platelet (White 1968a, White and 
Krivit 1967). In sectioned platelets they 
measure 25 nm in cross-sectional diameter (White 
1971a) forming a circumferential bundle of 8-20 
microtubules lying just under the platelet 
membrane (Behnke 1970c) (Figure 1). Nachmias et 
al. (1980) have presented evidence that the 
peripheral bundle is composed of a single coiled 
microtubule. 
An impressive group of proteins associated 
with the cytoskeleton have thus far been iden-
tified biochemically in platelets. These include 
actin (Probst and Luscher 1972), myosin (Booyse 
et al. 1971, Adelstein et al. 1971, Pollard et 
al. 1974), tropomyosin (Cohen and Cohen 1972), 
tubulin (Crawford and Castle 1976) actin binding 
protein (Lucas et al. 1976, Rosenberg et al. 
1981), alpha-act inin (Rosenberg and Stracher 
1981, Puszkin et al. 1978), vinculin (Billet et 
al. 1981) and P235 (Colli er and Wang 1982) as 
well as several regulators of actin polymeriza-
tion (Harris and Gooch 1981, Markey et al. 1981, 
Wang and Bryan 1981, Lind et al. 1982). The 
platelet contains actin in excess of myosin in a 
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molar ratio of 100 to 1 (Pollard 1975). This 
suggests that actin has a role in platelet struc-
ture independent of its role in force generation 
via actomyosin. Lind and Stossel (1982) review 
the evidence that pseudopod formation is 
controlled by rapid act in polymerization but is 
not dependent on myosin . In addition, the pre-
sence i n platelets of a microtrabecular filament 
network similar to that described in other cel l s 
(Buckley and Porter 1975, Wolosewick and Porter 
1979, Buckle y and Raju 1976) has been suggested 
by stereo whole mount electron microscopy (Lewis 
et al. 1980) and by transmission electron 
microscopy (TEM) of detergent treated whole 
mounts of adherent spread platelets (Mattson and 
Zuiches 1981b). Several recent reviews on the 
role of the platelet cytoskeleton in platelet 
physiology are highly recommended (Adelstein and 
Pollard 1978, Cohen et al. 1979, Gerrard et al. 
1981, Lind and Stossel 1982, Fox and Phillips 
1983, Nachmias 1983). 
Organelle zone: 
Organelles within this zone include 
mitochondria, glycogen particles, peroxisomes, 
dense-core granules, alpha granules, and lysoso-
mes (Figure 1). In response to a number of sti-
muli platelets secrete the contents of their 
dense-core granules and al pha-granules. This 
secretory response is known as the "rel ease 
reaction" (Grette 1962). Strong stimuli such as 
thrombin and high concentrations of collagen may 
also induce secretion of acid hydrolases from 
lysosomes (Kaplan 1981). The granules play an 
important role in the functional capacity of the 
platelet. The dense-core granules contain non-
metabolic adenine nucleotides (ADP and ATP), 
calcium and serotonin. Release of ADP promotes 
second wave aggregation in vitro. Inhibition of 
granule release by aspirin and other nonsteroidal 
anti-inflammatory drugs is accompanied by a 
measurable loss of second wave aggregation in 
vitro and a variable prolongation of the bleeding 
time. 
Alpha granules contain platelet factor 4 
(PF4), beta thromboglobulin (BTG), platelet 
fibrinogen, van Willebrand factor (factor 
VIII:VWF), fibronectin, and platelet der{ved 
growth factor. The contents of platelet granules 
are released by means of exocytosis (Holmsen 
1965) into the surface connected canalicular 
system (White 1973). 
Further information on platelet granule 
biochemistry, cel l biology, morphology and patho-
l ogy is provided by several recent reviews 
(Kaplan 1981, Holmsen 1980). 
The membrane systems: 
Channel s of the surface-connected open cana-
licular system (OCS) and the dense tubular system 
(DTS) make up the major part of this compartment. 
These two membrane systems are often found in 
intimate association with one anot her 
(Breton-Gorius and Gui chard 1972, White 1972b). 
The DTS, distinguished by it s content of 
amorphous materia l (Behnke 197Gb), is the site of 
calcium sequestration in the platelet (Gerrard et 
al. 1978); it has been likened to the sarco-
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tubules of muscle (White 1975) while the OCS has 
been compared to the transverse tubules of 
muscle. ca++;Mg++ ATPase activity is localized 
in the membranes of the DTS (Cutler et al. 1978) 
and calcium sequestration by the DTS is promoted 
by rises in platelet cyclic AMP. Many platelet 
inhibitors act by stimulating platelet adenylate 
cyclase to cause a rise in cyclic AMP (Haslam 
1973, Haslam et al. 1977). There is evidence 
that the DTS with its peroxidase activity is the 
site of prostaglandin synthesis (White 1972b, 
Gerrard and White 1978, Breton-Gorius and 
Guichard 1972). Platelet stimulation results in 
release of arachidonic acid from phospholipids in 
the platelet membrane. Arachidonic acid in turn 
is metabolized to yield thromboxane A2 (TxA2), a 
potent vasoconstrictor and aggregator of plate-
lets (Hamberg et al. 1975). Tv10 important 
enzymes in TxA2 synthesis are cyclooxygenase and 
thromboxane synthetase. Production of TxA2 can 
be blocked by acetylation of cyclooxygenase by 
aspirin. Inhibition of TxA2 synthesis results in 
inhibition of ADP release and second wave aggre-
gation. Prostaglandin synthesis in endothelial 
cells results in production of prostacyclin 
(PGI2), a powerful disaggregator and inhibitor of 
platelet aggregate fonnation as well as a vaso-
d i la tor (Moncada et al . 1976). Alternate pathways 
for platelet activation may involve release of 
lysophosphatidic acid from membrane phosphotidy-
linositol as this component is an effective 
platelet aggregator (Beauton et al. 1982). 
It is clear that an intact endothelial 
surface, with its antiaggregatory PGI2 activity, 
is a powerful deterrent to inappropriate thranbus 
fonnation. Loss of endothelial cells results in 
localized loss of this inhibitory activity and 
allows accumulation of platelets. 
The interaction of PGI2 and TxA2 as modula-
tors of platelet function appears to be through 
control of calcium flow from the DTS. Evidence 
supports PGI2 action via a rise in cyclic AMP 
which in turn activates a protein kinase that 
phosphorylates a protein regulator of calcium 
uptake into the DTS (Gerrard et al. 1978). 
Active prostaglandins (PGG2, PGH2, TxA2) do not 
measurably lower cyclic AMP, thus their action 
may be directly on calcium release, acting as 
ionophores. For a detailed discussion of the 
evidence in support of such a mechanism, the 
reader is referred to the review by Gerrard and 
White (1978). Additional reviews of the role of 
prostaglandins in platelet function are provided 
by Nalbandian and Henry (1978) and Cohen (1980). 
Platelet Shape 
Platelets are exquisitely sensitive cells 
which respond to minor mechanical and chemical 
stimuli by alterations in fonn and functional 
state. This sensitivity makes it very difficult 
to be certain that platelets under study are in 
fact "resting" and not altered by some stimulus. 
For this reason the search for appropriate anti-
coagulants and separation procedures, which pre-
serve the platelet in a fonn that closely 
approximates its native state, has been exten-
sive. Scanning electron microscopy has played a 
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major role in revealing the precise fonn of tile 
unactivated platelet and has also contributed to 
our understanding of the complex process of 
"shape change" that accompanies platelet activa-
tion (i.e. aggregation and adhesion reactions). 
The resting platelet (Figure lA-C): 
Preservation of platelets in their unstimu-
lated, circulating state is best achieved by 
drawing whole blood directly into aldehyde fixa-
tive (Hovig 1970a, Barnhart and Riddle 1967, 
Barnhart et al. 1972, Hattori 1972). By this 
technique the majority of platelets will appear 
as biconvex discs with no, or only a few, small 
pseudopods (Figure lA). Quantitation of the 
number of pseudopods in directly fixed platelets 
has been performed by several authors with good 
agreement. Barnhart and associates have found 
that 65-70% of directly fixed platelets are 
smooth and free of pseudopods in both dogs 
(Barnhart and Riddle 1967) and humans (Barnhart 
et al. 1972). The remaining platelets showed 
minor signs of activation; most of these remained 
flat discs with 1 or 2 small thin projections. 
By SEM, Hattori et al. (1969) found pseudopods to 
emerge exclusively from the marginal portion of 
the platelet at early stages of activation. 
Bifurcation of pseudopods has been described 
(Larrimer et al. 1970). Diameters of discoid 
platelets range from 2-4 µm with an average 
thickness of 0.4 to 0.8 µm (Hovig 1970a). Bigel 
and associates (1967) found the average diameter 
for normal adults to be 3.1 µm. The surface of 
the unstimulated platelet appears rough in com-
parison to red cells, and occasional small protu-
berances and several pit-like openings can be 
seen on the platelet surface (Figure lA). While 
as many as 30 or more surface openings may be 
seen by freeze fracture or thin section TEM 
(Werner and Morgenstern 1980), they are often 
difficult to visualize by SEM presumably due to 
their small size. By comparing SEM with TEM of 
the resting platelet, these surface pits 
correspond to openings of the surface-connected 
open canalicular system (Figure 18). Werner 
and Morgenstern (1980) found surface openings 
more concentrated near the periphery of the 
discoid platelet, but we have not seen this 
preferential distribution. 
TEM of the resting platelet demonstrates ran-
dom dispersion of organelles such as granules, 
mitochondria and glycogen particles. 
Microfilaments are not discernible by ordinary 
TEM techniques. Microtubules, on the other hand, 
are readily seen in sectioned platelets as a 
marginal band consisting of 8-20 individual 
microtubules (Behnke 1970a, 1970c, \.Jhite 1971a, 
Zucker-Franklin 1969) (Figures 18 ,C). Nachmias 
et al. (1977, 1980) have been able, after 
detergent extraction, to follow the peripheral 
microtubule for several turns and conclude that 
the microtubule bundle is composed of a single 
long microtubule arranged in a coil. Free ends 
never exceeded two, lending more evidence to 
Behnke's (1970c) earlier suggestion that the 
peripheral microtubu l e bundle is composed of a 
single long coiled microtubule. 
This coil of microtubules maintains the 
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discoid shape of the resting platelet. Evidence 
for this was obtained from experiments which 
showed that agents causing depolymerization of 
microtubules, i.e., cold (White and Krivit 1967, 
Zucker and Borelli 1954, Hovig 1970b) and colchi-
cine, vincristine and vinblastin (White 1968a, 
Hovig 1970b) result in disc to sphere transfor-
mation of platelets. 
Effects of preparative procedures Q!!_ platelet 
structure and function: 
Most studies of platelet function require 
collection of platelets in a solution appropriate 
for experimentation. Thus anticoagulated suspen-
sions of platelets in native plasma or an 
appropriate buffer are necessary. Clearly the 
mechanical stress associated with sample collec-
tion and centrifugation as well as the effects of 
various anticoagulants and salts can all 
influence the structure and function of the final 
product. 
The size of the needle used for venipuncture 
has been shown to have an effect on platelet 
structure. Hattori et al. (1977) found that a 23 
gauge needle produced 50% fewer disc-shaped (i.e. 
unstimulated) platelets than blood drawn through 
an 18 gauge needle. 
The choice of anticoagulant is especially 
important. Platelets drawn into citrate prior to 
fixation will most closely resemble directly-
fixed platelets; nevertheless they often show 
variable numbers of atypical fonns including 
spherical, elongated, and ellipsoid forms 
(Hattori et al. 1969, Zucker and Borelli 1954) 
(Figure 2A-C). Larrimer et al. (1970) 
demonstrated that ACO, modified ACD and heparin 
anticoagulation produce platelets (in PRP) simi-
lar in morphology to those in citrate. Zucker 
and Borelli (1954) demonstrated that temperature 
plays a major role in preservation of resting 
morphology; platelets collected in citrate and 
oxalate and maintained at 37°C were mainly 
discoid (85%) even though two thirds of the 
discoid platelets contained small pseudopods. At 
25°C fewer platelets remained discoid. Nachmias 
(1980) and Hovig (1970a,b) have confinned the 
beneficial effect of processing at 37°C. 
Phase microscopy shows that platelets exposed 
to cold (0-4°C) undergo shape changes converting 
from disc to "spi ney sphere" (Zucker and Borelli 
1954). By SEM these spiney spheres have highly 
irregular surfaces with numerous bud-like pseudo-
pods (Hovig 1970a,b) and only infrequent thin 
elongated pseudopods (Larrimer et al. 1970). 
Sphering is the result of cold-induced depoly-
merization of the marginal band of microtubules 
(White and Krivit 1967). No evidence of internal 
contraction, granule centralization or central 
migration of microtubules has been described by 
TEM. Rewanning to 37°C results in recovery of 
the discoid shape in about 30% of platelets, 
associated with refonnation of the microtubule 
bundle (White and Krivit 1967). 
Colchicine, which also depolymerizes microtu-
bules, causes platelet sphering (White 1968a, 
Behnke 1970a) in vitro as well as in vivo (Hovig 
197Gb). As with cold treatment depolymerization 
of microtubules and sphering with pseudopod for-
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mation are the major findings by TEM (White 
1968a). However colchicine induces changes in 
the DTS and produces inclusions which are not 
described with cold (White 1968b). 
While EDTA may be the preferred anticoagulant 
for certain preparative techniques, it should be 
kept in mind that it is a poor choice for preser-
vation of resting morphology. Platelets exposed 
to EDTA at 37°C lose their disc shape and become 
irregularly swollen with multiple pseudopods by 
phase contrast microscopy (Zucker and Borelli 
1954) (Figure 3A,B). Externally they appear 
similar to platelets sphered by exposure to cold, 
treated with colchicine or stimulated by ADP and 
thrombin. TEM studies (White 1968c), however, 
have demonstrated internal changes that are quite 
distinct from those present following stimulation 
with aggregating agents. The most prominent 
change is dilatation of the OCS. In contrast to 
cold and colchicine treatment, microtubules 
remain intact in their usual submembranous posi-
tion. Furthermore, granules do not migrate 
centrally as they do following ADP or thrombin 
stimulation. In White's study (1968c) these 
alterations were present as early as 13 min after 
exposure to EDTA. Prolonged incubation in EDTA 
(greater than 3-4 hours) leads to granule disso-
lution and swelling with an apparent increase in 
mean platelet volume by Coulter counter electro-
nic measurement (Mundschenk et al. 1976). 
If experimental procedures require separation 
of platelets from plasma, the maintenance of nor-
mal morphology and function is more difficult. 
In general, platelets separated from plasma by a 
variety of techniques including differential 
centrifugation (Mustard et al. 1972), gel filtra-
tion (Tangen et al. 1973) and albumin density 
gradient centrifugation (Walsh 1972) show com-
parable functional capacities if care is taken to 
avoid low temperature, excessive mechanical sti-
mulation, the introduction or relea se of agonist s 
such as ADP, and depletion of plasma proteins 
required for function (Mason et al. 1974). 
Functional differences are slight as measured by 
aggregability, adhesion to glass, and content and 
release of adenine nucleotides (Mason et al. 
1974). In contrast, morphology is not equally 
preserved by these techniques (Zucker et al. 
1974). 
Differential centrifugation by the Mustard 
technique (Mustard et al. 1972) at 37°C using /\.CD 
anticoagulant produced the best preserved resting 
morphology as studied by TEM. The important 
features of this technique are the use of 37°C 
rather than room temperature, the presence of 
apyrase to inhibit any nucleotide released during 
preparation, and the phosphate carbonate buffer 
which supports preservation of platelet shape and 
function. In this same study gel filtration at 
room temperature produced moderate irregularities 
in morphology with a few pseudopods. However 
platelets in general remained discoid and 
organelles remained dispersed. Gel filtration is 
preferred to centrifugation by some investigators 
(Akkerman et al. 1978). Platelets separated by 
gel filtration at 37°C are less activated than 
those separated at room temperature (Nachmias 
1980). Of the three separation techniques, albu-
min density gradient centrifugation showed the 
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Use of SEM to St udy Platelets 
Figure 1 A-C. Ultrastructure of human discoid 
unstimulated plat elets fixed immec!Tafely by 
drawing blood dir ect ly into glutaraldehyde:- A: 
SEM. Ba nd C: TEM. The discoid shape of the 
unstimulated platelet i s best appreciated by SEM 
in A. Openings of t he sur fa ce connected open cana-
licular system (OCS) are barely perceptible as 
minute pit-lik e depress i ons on the sur fa ce 
(arrows). Position of underlying granul es i s not 
discernib l e on the platelet surface. In the 
transm i ssion el ectro n micrograph B, di sco id unsti-
mul ated plate l ets show randomly dispersed orga-
nelles in clu ding dense core granules (D), 
al pha-granu l es(A), mi toc hondria (M), and masses of 
glycogen particles (G) as well as channel s of OCS 
(*). Dense core gra nules are distinguished from 
alpha -granules by their bull's eye appearance. 
The peripheral band of mi crotubules (MT) i s seen 
in cross section in micrographs Band Cat the 
poles of the di sco id pl ate l ets. The trilaminar 
structure of the plasma membrane i s evident in C 
(arrowhead). A and B: Bars = 1 mi crometer; C: Bar 
= 0.1 micrometer. 
Figure 2 A-C. Ultrastructure of platel ets fixed 
after~ p)eparat i on of citrated pl atele t- rich 
pl asma PRP. A: SEM. Band C: TEM. In th e 
sca nning micrograph A, note t he mild act ivat i on 
that occurs dur in g the prepara ti on of PRP. Short 
blu nt (arrowheads) and el ongated thin (arrows) 
pseudopods are numerous. Most plate l ets remain 
discoid but occas i onal plate l ets are sphered. A 
red eel l (RBC) is present in the preparation. 
Transmission electron micrographs of pl ate l ets 
fixed in PRP, Band C, show t he preservation of 
the discoid shape as well as random di sperson of 
organe ll es, and absence of a contracti l e wave. 
The main manifestation of early, mil d st imulat i on 
is pseudopod formation (arrows). Hi gher magnif i -
cation in C demonstrates preservation of the 
peripheral bundle of microtubules (MT). Thin 
pseudopods appear to pref erentia ll y fonn from the 
margin of discoid plate l ets (arrows). Bars = 1 
micrometer. 
least preserva tio n of morphology (Zucker et al. 
1974). Improvements in albumin density gradient 
separat i on techniques which include addition of 
apyrase to the separa tion buffer are reported to 
have improved the preservation of ultrastructure 
v1ith this procedure (Wal sh et al. 1977). Among 
the newer separat ion techn iques, Stract an 
gradients have been reported to preserve platelet 
structure while metrizamide produces structural 
a lt erations (Corash et al. 1977). Choice of 
buffer wi 11 al so influence the final product. 
Tris buffers produce morphologic (Zucker et al. 
1974) as well as functional abnonnalities (Lages 
et al. 1975) while imidazole and triethanolamine 
buffer s produce functional defects (Davis and 
Phillip s 1971). Frojmovic and Milton (1982) 
further recommend that an atmosphere of 5-6% 
CO2 and a pH of 7.4 ±_ 0.1 are optimal. 
Glutaraldehyde in a wide range of con-
centrations (0.1 - 7.1%) is an effective fixative 
for both scanning and transmission electron 
microscopy of platelets (Barnhart and Riddle 
1967, Larrimer et al. 1970, Hovig 1970a,b, 
Barnhart et al . 1972, Hattori 1972, Mattson et 
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Fi gure 3 A-B. Ultrastructure of platelets 
coll ected ..i!:1_ EDTA anticoagulant. A: SEM. B: TEM. 
Note loss of disco id shape. Sphered platelets 
s how infr equent pseudopods (white arrow). Openings 
of the OCS are visible as pits on the surface 
(bl ack arrows). Transmission el ectron micrograph 
of EDTA-anticoagu l ated platelets in B shows 
absence of microtubules, marked dilatation of OCS 
(*), and paucity of dense core and alpha -granu l es. 
Bars= 1 micrometer. 
al. 1977). Large volumes of fixative-buffer 
solution containing relatively low concentrat i ons 
of glutaraldehyde are recommended when platelets 
are to be fixed in whole blood or plasma in order 
to avoid coagulation of plasma protein s (Bess i s 
and Weed 1972, White 1968d, Mattson et al. 1977). 
Buffer concentration appears to be more critical 
than glutaraldehyde concentration in preservation 
of ultrastructure as buffer is more freely dif-
fusible than glutaraldehyde into the cell and 
therefore produces a greater osmotic effect 
(Arborgh et al. 1976, Barnhart and Riddle 1967). 
We have found that initial preservation in 0.1% 
glutaraldehyde in O.lM cacodylate buffer pH 7.4 
gives excellent preservation for both SEM and TEM 
J. C. Mattson 
(Mattson et al. 1977). vJhile many early studies 
of platelet three-dimensional structure yielded 
useful information from air dried preparations, 
for optimal preservation of orientation of 
pseudopods and avoidance of collapse of cells, 
critical point drying (Polliack et al. 1973) or 
lyophilization (MJ Murphy 1972) is preferred. 
Shape Change 
Morphologic changes have been observed in 
platelets both in response to stimuli which 
initiate aggregate formation and as part of the 
platelet response during adhesion to surfaces. 
vJhile these morphologic changes closely parallel 
the biochemical and functional alterations which 
occur during aggregation, granule release, and 
adhesion, they appear to be separable events. 
The search for the role of shape change in these 
functional reactions has led to a variety of 
structural-functional studies employing numerous 
agonists and inhibitors. vJhile these studies 
have clearly indicated that certain morphologic 
events can be correlated to structural rearrang e-
ments within the platelet, the role of shape 
change in augmenting platelet function has yet to 
be fully elucidated. 
Morphologic alterations that accompany 
aggregation: 
The platelet's response to stimu li is depen-
dent on the nature, strength, and duration of the 
stimulus as well as the responsiveness of the 
platelet itself. vJith suboptimal stimuli, acti-
vation will be transient and reversible but with 
stronger stimuli, irreversible activation will 
occur (Zucker and Peterson 1970, Larrimer et al. 
1970, Barnhart et al. 1972). 
The addition of most platelet stimulators to 
platelets in suspension results in dramatic 
morphologic changes commonly referred to as 
platelet "shape change". Documentation of shape 
change may be based on direct microscopic obser-
vation or on indirect measurement of light 
transmission by aggregometry (Born 1970). vJith 
aggregometry, disc to sphere transformation is 
observed in a stirred suspension of platelets as 
a decrease in light transmission as well as a 
decrease in the amplitude of the recorder pen 
oscillations (Latimer et al. 1977, O'Brien 1970). 
The change in amplitude is due to light-
deflecting differences between discs and spheres. 
Because discoid platelets are asymmetrical, they 
are oriented by the shearing forces of the stir 
bar to produce a visible swirl which is recorded 
as rapid oscillations. Immediately after addi-
tion of an aggregating agent, discoid platelets 
transform into spheres which no longer show the 
swirl effect and the oscillations disappear. 
By SEM, the two major features of agonist-
induced shape change are sphering and extension 
of surface projections (vJhite 1974b). These sur-
face projections are variably referred to as 
microspikes, filopodia (Nachmias et al. 1979) or 
pseudopods (Hovig 1970a,b, Barnhart et al. 1972). 
Surface projections may be short, blunt and 
generally rounded, or thin, elongated and 
cyl ind ri cal • When there is a preponderance of 
elongated, thin pseudopods, platelets are often 
referred to as "dendritic" in fonn (Bessis 1973, 
Hovig 1970b). For an excellent discussion of 
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platelet shape change the reader is referred to 
the review by \~hite (1974b). 
ADP and thrombin (Figure 4A-G): 
While platelets respond to many diverse sti-
muli, including mechanical shear forces, chemi-
cal agonists and inhibitors, and particulates 
such as latex, bacteria and collagen fibrils, the 
process of cell activation has been best worked 
out for ADP and thrombin stimulation. 
vJithin seconds following activation by ADP 
(or thrombin), platelets transform from discs to 
spheres and numerous short bulbous and a few 
longer thin surface projections appear (White 
1974b, 1968d, 1971b, Barnhart et al. 1972, Walsh 
and Barnhart 1973, Barnhart 1978, Larrimer et al. 
1970, Shoop et al. 1970, Hovig 1970a,b, Hattori 
et al. 1969) (Figure 4A). Hattori (1972) 
suggests from observation of samples taken 5 
seconds after ADP addition that bulbous, blunt 
projections arising from the flat face of the 
discoid platelet precede sphering. We have made 
similar observations (Mattson and Craft, 
unpublished observations) White (1974b) has 
observed that the earliest change is formation of 
short pseudopods most frequently at or near the 
edge of the disc. This type of pseudopod with 
its actin filament core is likely related to the 
activation-induced rapid polymerization of actin 
reported by many investigators, while the blunt 
knobby surface undulations seen in early stimu l a-
tion may be related to the internal reorganiza-
tion that accompanies internal contraction. We 
have never observed parallel bundles of actin 
filaments in these knobby, irregular surface con-
volutions (Figure 4B). vJhile sphered platelets 
are often referred to as swollen, there is not 
general agreement that true volume increases 
accompany shape change. The mean platelet volume 
(MPV) of discoid platelets is approximatel y 4-8 
µm3 (Frojmovic and Milton 1982), while the 
reported MPV of EDTA sphered platelets varies 
from 7.7-10.3 µm3 (Mundschenk et al. 1976). 
Variation in the reported volumes for sphered 
platelets appears to be due in part to differen-
ces in methodol ogy and anticoagulant. In addi-
tion Bessman et al. (1982) have demonstrated that 
there is a nonlinear inverse relationship between 
MPV and platelet count which needs to be taken 
into account in interpretation of volume data. 
Investigators using Coulter counter measurements 
of mean platelet volume report increases in pla-
telet volume (Bull and Zucker 1965, Laufer et al. 
1979) while those estimating volume by microhema-
tocrit (Born 1970) and microscopic measurements 
(Milton and Frojmovic, 1977, 1979) find no change 
in volume following agonist-induced shape change. 
For an in-depth discussion of surface area and 
volume change in st imulated platelets, the reader 
is referred to the recent review by Frojmovic and 
Milton (1982). 
Following ADP induced shape change, loose 
aggregates initially fonn (Hovig 1970a, Barnhart 
et al. 1972) in which individual platelets retain 
their discrete identity (Figure 4C,D). Given a 
sufficient stimulus, these ultimately become 
tightly organized aggregates of fus ed platelets 
(Figure 4E,F). By SEM these irreversible aggre-
gates resemble coral with numerous fingers and 
ridges fanned by the fused platelet masses 
Use of SEM to Study Platelets 
(Figure 4E). With low concentrations of ADP 
irreversible aggregates do not fonn and disaggre-
gation occurs; this is associated with restora-
tion of the discoid fonn. 
Changes in surface contour are associated 
with internal transfonnations. The randomly 
dispersed organelles of the resting platelet 
migrate centrally to fonn a nucleoid of granules 
and contractile filaments (Figure 4B). Gerrard 
et al. (1979) have demonstrated that the contrac-
tile wave is oriented toward the aggregate center 
and thus the centralized organelles and contrac-
tile apparatus will be displaced in this direc-
tion. This reorganization is associated with 
central migration of the peripheral microtubular 
bundle (White 1979) resulting in loss of the 
discoid shape and sphering. Central displacement 
of microtubules is apparently accomplished by 
depolymerization of tubulin with repolymerization 
at the new location. A transient decrease in 
polymerized tubulin content of platelets has been 
demonstrated immediately following stimulation by 
thrombin, ADP, epinephrine, or collagen with 
recovery of baseline polymerization by 1-4 min 
(Steiner and Ikeda 1979). While thrombin and ADP 
induced internal reorganization are identical, 
central fusion of granules has been reported with 
thrombin stimulation but not with ADP stimulation 
(White 1968b). 
The state of microfilament polymerization in 
the resting and activated cell has also been an 
area of considerable interest since both cell 
shape and internal reorganization require par-
ticipation of cytoskeletal components. In aggre-
gation centralization of granules and microtubule 
coils is accompanied by a wave of contraction 
that is visualized as the appearance of a dense 
mass of poorly defined microfilaments in the cell 
center (White 1974a,b) (Figure 4B). 
Because ultrastructural visualization of 
filament organization is exceedingly difficult, 
most studies on the state of contractile protein 
polymerization have used biochemical assays. 
Nachmias and her colleagues (1977, 1979), using 
the local anesthetics lidocaine and tetracaine 
which are inhibitors of microfilament polymeriza-
tion, found that actin in the pseudopod-free, 
resting platelet is mainly monomeric or non-
polymerized G-actin. A rapid increase in poly-
merized actin (F-actin) following chilling, 
thrombin and ADP stimulation has been 
demonstrated (Phillips et al . 1980, Jennings and 
Phillips 1981, Pribluda et al. 1981). Fox et al. 
(1981) found 40% of total actin was F-actin in 
resting platelets that were lysed under stabi-
lizing conditions; this rose to 65% F-actin 
following thrombin stimulation. Others have 
reported between 20 and 50% F-actin in unstimu-
lated platelets using a DNase I inhibition assay 
(Gitler et al. 1980, Carlsson et al. 1979, 
Jennings et al. 1981, Pribluda et al. 1981), 
even in the presence of tetracaine inhibition 
(Davies and Palek, 1982). F-actin in the resting 
platelet may represent a stable network of fila-
ments responsible for the spatial relationships 
of organelles. This stable system of filaments 
presumably includes the submembranous filaments 
which are intimately associated with the microtu-
bular coil on its internal side and the plasma 
membrane on its external aspect. Actin filaments 
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which fonn following stimulation are present in 
bundles in pseudopods and within the platelet 
body (Nachmias 1980, Jennings et al. 1981, 
Gonella and Nachmias 1981). While actin bundles 
produced by stimulation are sensitive to depoly-
merization by cytochalasins, filamentous actin 
present in unstimulated platelets is not (Fox and 
Phillips 1981). 
Agonist-induced cytoskeletal changes are 
associated with simultaneous membrane changes. 
Association of membrane GP !lb-Illa complex 
with the underlying cytoskeleton occurs following 
thrombin (Phillips et al. 1980) and conconavalin 
A (Painter and Ginsberg 1982) aggregation but has 
not been observed following ADP aggregation 
(Rol:man et al. 1982). These reported differences 
are surprising since ADP and thrombin produce 
almost indistinguishable morphologic changes 
(White 1968d) and both require fibrinogen binding 
to GP !lb-Illa complex for aggregation to occur. 
Epinephrine and other biologic amines (Figure 
5A-C): 
The question of whether shape change is 
required for either aggregation or granule 
release is raised by studies on epinephrine 
induced aggregation. This agonist produces a 
two-wave aggregation response similar to that 
seen with ADP. The primary wave is induced by 
the epinephrine while the second wave is mediated 
by thromboxane A2 production and ADP release from 
dense-core granules. The primary wave of epi-
nephrine aggregation, unlike ADP or thrombin sti-
mulation, produces no shape change, no granule 
centralization and no contractile wave as evi-
denced by centralized filaments (Figure 5A-C). 
Nevertheless granule release can occur. A more 
recent role for epinephrine in platelet reactions 
has been postulated by Rao et al. (1980, 1981). 
These authors suggest that alpha-adrenergic 
receptor occupancy directly alters the platelet 
membrane, allowing irreversible aggregation to 
occur in response to a second agonist even in the 
absence of prostaglandin synthesis or release of 
granule constituents. 
The effect of biologic amines on platelets is 
not unifonn. Epinephrine, norepinephrine and 
serotonin induce aggregation and enhance 
spreading on a formvar surface (Barnha~t et al. 
1972). Serotonin, in contrast to epinephrine, 
produces platelet sphering with marked surface 
convolutions as seen by SEM. Another vasoactive 
amine, histamine, acts as a platelet inhibitor 
which diminishes contact-activated shape change 
(Barnhart et al. 1972). 
Coll a gen: 
Collagen is one of the strongest platelet 
agonists. Collagen induced shape change is simi-
lar in many respects to that seen with ADP and 
thrombin (Larrimer et al. 1970). Disc to sphere 
transformation is rapid and numerous long thin 
psuedopods are produced (Figure 6). Barnhart and 
Noonan (1978) demonstrated that as many as 16-20 
pseudopods may be present per platelet. Terminal 
bulbous swellings have been described at the tips 
of pseudopods by SEM (Polasek 1982). By TEM 
these endings contain multivesicular structures 
(Warren and Vales 1972a; b). 
J. c. Mattson 
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Figure 4 A-G. Ultrastructure of ADP aggregation . A 
and B: Samples harvested at 5 seconds after addi-
tion of ADP and examined by SEM (A) and TEM (B). 
C and D: Samples harvested at 1 minute and exa-
mined by SEM (C) and TEM (u). E and F: Samples 
harvested at 3 minutes and examined by SEM (E) and 
TEM (F). G: Typical 2 wave ADP aggregation curve 
demonstrating points of sampling. The earliest (5 
second) shape change induced by ADP is seen in A 
and B. In A, SEM demonstrates the disc to sphere 
transformation. While thin pseudopods are present 
(arrow), the major surface alteration is the pre-
sence of blunt, short convolutions which give the 
platelets a cerebroid appearance. Openings of the 
OCS are not present on the crests of these con-
volutions as seen by SEM in A, but appear to exit 
from the bases of these projections as 
demonstrated by TEM in B (arrows). By TEM in B, 
centralization of organelles (0) is evident as is 
concentration of densely staining cytoplasmic 
matrix (M). This condensed matrix is presumably 
composed of contractile elements. Note the ,sur-
face convolutions are devoid of organelles and the 
microtubule bundle is no longer present at the 
platelet periphery. C and D demonstrate a loose 
reversible platelet aggregate from a sample 
collected at the peak of primary wave aggregation 
(1 minute). By SEM (C), individual platelets are 
ea s ily identified within the aggregate. Entrapped 
red cells (RBC) and a rare lymphocyte (L) are 
seen. TEM in D demonstrates that the integrity of 
individual platelets within the primary aggregate 
is preserved. In E and F the irreversible aggre-
gates harvested at the peak of second wave aggre-
gation (3 minutes) show loss of individual 
platelet integrity. By SEM (E), the aggregates 
resemble a coral reef with projection of wide 
ridges composed of fused platelets. The surface 
has a rough cobblestone appearance and distinct 
margins of platelets are not discerned. 
Occasionally an intact platelet is recognizable on 
the surface (arrow). By TEM (F), loss of platelet 
contents and focal disruption of membranes are 
seen (Circle). Bars =l micrometer. (Micrograph A 
is reprinted with permission from Stain Technol 
52: 151-158, 1977). 
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Platelets activated in vivo: 
Increased numbers of abnormal forms and 
sphered platelets both with and without pseudo-
pods have been identified by SEM in immediately 
fixed blood from patients with disseminated 
intravascular thrombosis (DIC), idiopathic throm-
bocytopenia (ITP), preleukemia, acute promyelocy-
tic leukemia, and pregnancy (Hattori et al. 1979) 
as well as in spur cell anemia secondary to hepa-
tocellular disease (Doll 1982). SEM has been 
used to study the interaction of platelets with 
blood borne tumor cells. Some tumor cells are 
able to activate platelets to change shape and 
form aggregates in vitro and in vivo (Figure 7). 
The presence of aggregates distant from the 
tumor suggests that soluble tumor products in the 
media may be responsible for the aggregation of 
platelets. Platelet aggregation by tumor cells 
in the circulation does not appear to be essen-
tial for tumor eel l metastasis in the spontaneous 
metastasis animal model (Estrada, 1983). The 
morphology of platelet tumor cell interaction has 
been the subject of a recent review (Warren 
1978). 
Several basic substances including polyly-
sine, protamine, and polyornithine are strong 
platelet stimuli which induce shape change and 
aggregation in vitro. It is therefore of 
interest that a biologic basic substance, myelin 
basic protein (MBP), induces dramatic shape 
changes although no release has been demonstrated 
( Laubscher et al. 1979). 
Contact activation of adherent platelets (Figure 
8A-C): 
Platelet adhesion is a complex process in 
which at least 3 partially independent events, 
cell attachment, morphologic changes (i.e. 
spreading) and surface induced release, par-
ticipate (Baumgartner et al. 1976). The morpho-
logic changes which accompany adhesion bear many 
similarities to those described in aggregating 
platelets in suspension. These changes can be 
visualized by light microscopy as platelets react 
to a glass surface and have been well studied by 
dark field (Fonio and Schwendener 1942), phase 
contrast (Bessis and Tabius 1955) and differen-
tial interference contrast (DIC) (Allen et al. 
1979, Barnhart et al. 1972) microscopy. Bessis 
and h1s coworkers characterized the successive 
stages of platelet shape change, labeling the 
evolving pl ate let forms round or di scoi da l , 
dendritic, transitional and spread (Bessis and 
Bricka 1952, Bessis and Burnstein 1949, Bessis 
and Tabius 1955). More recent studies by Allen 
and coworkers (1979) combined DIC cine-
photography of viable platelets with scanning 
electron microscopy of fixed platelets to obtain 
further detail on surface structural changes. 
They observed early extension of both short non-
motile protuberances and longer cylindrical, 
tapered pseudopods which extended and retracted 
until surface contact was made. Platelet 
cytoplasm (hyalomere) spread radially either sym-
metrically or asymmetrically. Hyalomere 
spreading could occur whether or not preceded by 
pseudopodial activity. When preceded by pseudo-
pods, the hyaloplasm spread as a web connecting 
adjacent projections. Granules were concentrated 
J. C. Mattson 
Figure 6. Scanning electron micrograph of collagen 
induced aggregation. Disc to sphere transfor-
mation is accompanied by extensive pseudopod for-
mation (Arrows). Collagen fibrils (C) are present 
in the background. Bar= 1 micrometer. 
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Figure 5 A-C. Ultrastructure of epinephrine 
induced primary wave aggregates. A and B: SEM 
and C: TEM. Samples of primary aggregates sho1~ 
that sphering does not accompany primary wave 
aggregation induced by epinephrine. By SEM (A) 
aggregates appear composed of plump but discoid 
platelets. At higher magnification (B) these pla-
telets show a few thin pseudopods but no surface 
convolutions. TEM (C) of these primary aggregates 
shows little evidence of centralization of orga-
nelles or condensation of cytoplasmic matrix typi-
cal of ADP aggregation. Bars= 1 micrometer. 
Figure 7. Platelet-tumor cell interaction. 
Scanning electron micrograph demonstrates the in 
vitro activation of platelets (P) by tumor cells 
(T) derived from rat 12763 adenocarcinoma (clo ne 
MTF7). Aggregation occurs both with platelets in 
contact with tumor cells and with platelets 
distant from tumor cells suggesting that a tumor 
product in the media promotes aggregation. 
(Reproduced with permission of J Estrada). 
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centrally into a hillock reminiscent of the gra-
nule centralization observed in platelet aggrega-
tes (White 1974a). As spreading proceeded, this 
hillock flattened. Using mepacrine labeling, 
these authors were able to observe dense body 
release. They also observed that platelets 
settling on top of spread platelets were blocked 
from the substrate stimulus and did not spread, 
although they did partially degranulate and 
formed many pseudopods which interlocked as 
aggregates formed. 
The sequence of morphologic changes on form-
var are similar to those observed with glass 
activated platelets (Lewis et al. 1980, Barnhart 
and Riddle 1967, Mattson 1981) (Figure 8A-C). 
Using SEM stereomicroscopy of pigeon thrombocytes 
adherent to formvar, Taylor and Lewis (1981) 
extended Allen's observations and demonstrated 
that attachment of pseudopodia and of the 
spreading edge of the hyalomere is discontinuous. 
Stereo whole mount TEM demonstrated fine filament 
strands connecting the uplifted membrane to the 
formvar surface. Several investigators 
(Braunsteiner and Pakesch 1956, Rebuck and Riddle 
1964, Riddle and Schatz 1970, Barnhart and Riddle 
1967, Barnhart et al. 1970, 1972, and Barnhart 
and Noonan 1978) have used formvar activation as 
the basis for a functional assay of platelet 
reactivity. Platelets in whole blood, stimulated 
by a timed exposure to formvar can be fixed as 
whole mounts and examined by either TEM or SEM. 
Activated forms, s imilar to those described by 
Bessis (1973) and Allen et al. (1979) on glass, 
include round, abortive-dendritic, dendritic, 
intermediate, and spread forms (Figure 8); these 
can be quantitated to give an index of reac-
tivity. In addition, aggregrate formation can be 
quantitated. Hyperactivity, manifested as 
increased spreading and greater aggregate for-
mation, has been detected in patients with 
myocardial infarction (MI) in the immediate post 
Figure 8 A-C. Ultrastructure of contact activated 
platelets. A and B: TEM. C: SEM. Transmiss ion 
electron micrographs A and B demonstrate whole 
mount preparations of adherent and spread ing pla-
telets on carbon-stabilized formvar films. 
Extraction-fixation in 2.5% glutaraldehyde con-
taining 1% NP40 allows visualization of cytoskele-
ton in spread forms. Early forms are seen in A; 
these include sphered (S), abort ive-dendritic 
(AD), and dendritic (D) forms. In 8, later spread 
forms are demonstrated. As spreading proceeds, 
intermediate forms ( I) show cytoplasmic spreading 
between pseudopods. Later forms include i ncomp le-
tel y (IS) and completely spread (CS) platelets. 
Centralization of organelles (circle) is clearly 
evident in spreading platelets, and rearrangement 
of cytoskeletal filaments (F) can be seen. 
Scanning electron micrograph C of adherent plate-
lets demonstrates the 3-dimensional appearance of 
contact activated platelets. Adhesive substrate 
is a ca rbon-formva r coated glass covers lip; con-
tact time 60 minutes. Dendritic platelets (D) 
show numerous thin pseudopods radiating from plump 
sphered bodies. Spread platelets have centralized 
granules which first appear as a central hillock 
(H) and then flatten revealing the outline of 
individual granules (G). Bars = 1 micrometer. 
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MI period (100%) as well as several months later 
(67%) (Riddle and Schatz 1970). Similar 
increases in reactivity to glass and collagen has 
been described in ischemic heart disease by Aznar 
et al. (1979). Hyper-reactivity to fonnvar has 
also been seen in patients with arthritis (Riddle 
et al. 1981) as well as in patients with acute 
stroke (88%) (Gilroy et al. 1969, Barnhart et al. 
1970) but in only 36% of patients with chronic 
cerebrovascular disease (Walsh et al. 1975). 
Fibrinolytic products in low concentration 
enhance platelet contact activation while in high 
concentrations are inhibitory (Barnhart and 
Riddle 1967). 
This system has also been useful in eva-
luating platelet reaction to various chemical 
stimuli. Enhanced platelet activation by biolo-
gic amines (serotonin, epinephrine, and 
norepinephrine), thrombin, collagen, adenine 
nucleotides, fibrin split products and low con-
centrations of Hageman factor has been 
demonstrated (Barnhart et al. 1970, 1972, 
Barnhart and Riddle 1967, Walsh and Barnhart 
1973). In addition these authors have studied 
inhibition of membrane reactivity by low molecu-
lar weight dextran, ouabain, histamine, urea in 
glucose, and sodium metabisulfite and acetylsali-
cylic acid (Barnhart et al. 1970, 1972) using SEM 
as an adjunct to TEM and DIC light microscopy. 
The adherence of platelets to biological 
substrates initiates events similar to those 
described with glass and fom,var activation. 
Scanning electron microscopy of human platelets 
adherent to a collagen coated substrate shows a 
similar sequence of morphologic changes (Elbert 
et al. 1979). With conversion of discoid plate-
lets to spheres accompanied by a progressive 
increase over time in bulbous and fine elongated 
pseudopods, platelet spreading and ultimate 
aggregate fom,ation developed over a 16 minute 
time course. These authors reported that 
PGiz did not apparently inhibit adhesion 
(st icking) to collagen but sphering and pseudopod 
fom,ation were retarded and aggregates were fewer 
and smaller. Aspirin (10 mg%) inhibited aggrega-
tion but not adhesion on the collagen substrate 
and morphologic transfom,ation was abnom,al with 
more pleomorphic fonns. Sulfinpyrazene (10 mg%) 
proved least effective as an inhibitor producing 
no substantial decrease in aggregate size 
although morphologic alterations were similar to 
those seen with aspirin. 
A role for the adhesive protein fibronectin 
in platelet-collagen interactions has been postu-
lated (Bensusan et al. 1978). Fibronectin is 
present in platelet alpha-granules (Zucker et al. 
1979, Plow et al. 1979) and is released upon sti-
mulation by thrombin and high concentrations of 
collagen (Zucker et al. 1979). Fibronectin can 
be identified on the platelet surface following 
secretion (Ginsberg et al. 1981) and on spread 
platelets adherent to collagen fibers or plastic, 
but not on unstimulated gel-filtered platelets 
(Lahav and Hynes 1981). Santoro and Cunningham 
(1979) demonstrated only a slight reduction in 
adhesion after treatment of washed platelets with 
anti-fibronectin antibody or Fab fragments. On 
the other hand, platelet spreading on both colla-
gen and fibrinogen substrates appears to be 
potentiated by fibronectin (Grinnell et al. 
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1979). Further support for this is found in SEM 
studies showing an increase in platelet adhes ion 
to fibronectin-treated fibrillar collagen with 
marked potentiation of spreading to fom, a pave-
ment like covering of the substrate (Koteliansky 
et al. 1981). The role of fibronect in in adhe-
sion is far from clear, but from the data 
available it may have a major role in supporting 
platelet spreading with a more minor par-
ticipation in promotion of the attachment or con-
tact phase of adhesion. 
Platelets adherent to glass beads retrieved 
from glass bead retention columns show the same 
morphologic transfom,ation v1ith development of 
dendritic and spread fom,s as described with 
glass slides, fom,var, and collagen. PGI2 
inhibition of glass bead retention is due to 
inhibition of aggregation. Platelet attachment 
appears to be intact but spreading is markedly 
inhibited (Hattori et al. 1974a,b, Tsao and 
Krajewski 1982). Inhibition of spreading has 
been demonstrated by cold (Bessis 1973), cytocha-
lasin B (Taylor and Lewis 1981) and PGI2 (Tsao 
and Kraje\1ski 1982). In all instances \~hen these 
agents or conditions were introduced after 
spreading had occurred, retraction of spread 
hyaloplasm left long fine pseudopods behind 
attached to the substrate. 
Cytoskeletal architecture in spreading plate-
lets has been studied using fom,var as the acti-
vating substrate and partial detergent extraction 
(Nachmias and Sullender 1978, Nachmias 1980, 
Mattson and Zuiches 1981b, Mattson 1981), whole 
mount electron microscopy (Lewis et al. 1980, 
Taylor and Lewis 1981) and high voltage electron 
microscopy (Albrecht and Lewis 1982) to visualize 
the platelet cytoskeleton. Cytoskeletal archi-
tecture in detergent extracted platelets is 
demonstrated in Figure 8B. 
Cytoskeletal organization in dendritic plate-
lets shows radial extension of bundles of micro-
filaments into pseudopods, while in the fully 
spread platelet there is reorientation of micro-
filament bundles into circumferential loose 
parallel arrays (Lewis et al. 1980, Mattson and 
Zuiches 198la,b, Mattson 1981, Nachmias and 
Sul lender 1978, Nachmias 1980). A microtrabecu-
lar lattice of shorter fine filaments is evident 
throughout the platelet cytoplasm and there is a 
condensed filament network in the submembranous 
cortex (Lewis et al. 1980, Mattson and Zuiches 
1981a, b). This reorganization of the platelet 
cytoskeleton parallels platelet spreading and 
granule release (Allen et al. 1979). Debus et 
al. (1981) have identified by immunofluorescence 
that the circumferential microfilaments are actin 
and that myosin is concentrated both centrally 
and at the margin of the spread platelet. An 
organization of circumferential actin filaments 
and central concentration of myosin is consistent 
with the hypothesis that actomyosin interactions 
result in contraction of actin microfilaments to 
provide force generation for granule release 
(Gerrard et al. 1981). Similarly the continuity 
of radial filaments in pseudopods with the more 
central circumferential filaments would allow 
central actomyosin contraction to play a role in 
pseudopod retraction. 
The mi crotubu le coil , important to maintenance 
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of the discoid shape of the unstimulated plate-
let, appears to reorganize in the contact-
activated platelet but the precise sequence of 
events is unclear. Using immunofluorescence with 
anti-tubulin antibodies, Debus et al. (1981) have 
observed brightly stained microtubular rings with 
mean maximum diameters of 3.4 µmin discoid pla-
telets. In dendritic platelets these coils 
decreased in diameter to 2.1 + 0.44 µm with one 
or two arms projecting out from the ring presu-
mably into pseudopods. In cor.t rast Reeber et 
al. (1983) have observed a gradual breakdown of 
the microtubule ring during spreading on 
poly-L-lysine coated surfaces. In these studies 
anti-tubulin staining became diffuse within the 
platelet body with bright staining of some 
pseudopodia. One can see similar diffusely 
stained dendritic platelets among the spread pla-
telets in photomicrographs taken at 2 hrs by 
Debus et al. (1981). Whether this diffuse 
staining represents depolymerization of microtu-
bules is not clear nor is it clear in comparing 
the two studies whether this phase precedes or 
follows the formation of a microtubular ring of 
decreased diameter. Immunofluorescence of more 
fully spread platelets in 2 hr specimens (Debus 
et al. 1981) showed various complex arrangements 
of curving microtubules seen both close to the 
central granul omere and in the distal spreading 
cytoplasm suggesting that if depolymerization 
occurs, reformation of microtubules takes place 
in later stages of spreading. Ult rast ructura l 
studies support the concept of microtubule 
reorganization during platelet spreading on sur-
faces (Lewis et al. 1980, 1982, Mattson and 
Zuiches 198la,b). Using whole mount stereo 
electron microscopy of platelets from the African 
green monkey, Lewis et al. (1982) observed that 
during the early stages of adhesion, microtubules 
assumed a radial orientation into the pseudopods 
of dendritic platelets. As hyalomere spreading 
proceeded, microtubules paralleled the major axes 
of the cells until in fully spread platelets 
the microtubules were present in a diffuse cir-
cumferential pattern. Replacement of the 
coiled microtubule ring of resting platelets with 
gently curving circumferential microtubules in 
the cytoplasm of the fully spread platelet has 
also been observed in human platelets using 
detergent treated whole mounts (Mattson and 
Zuiches 198la,b). 
There is evidence that these changes in 
microtubule organization may not, be required for 
platelet spreading to occur. Lewis et al. (1982) 
have demonstrated that colchicineand vinblastin 
treatment of platelets, which dissociates micro-
tubules, does not eliminate spreading although a 
slight reduction in the percentage of fully 
spread cells was observed. Similarly, prevention 
of depolymerization of microtubules using the 
microtubule stabilizing agent, Taxol, does not 
interfere with platelet shape change (White and 
Sauk,1984). One might speculate from the available 
data that microtubule reorganization occurs as a 
secondary event during adhesion-associated shape 
change. A reasonable sequence of events might 
be: (1) contact activation of the platelet with 
centralization of granules and a decrease in the 
microtubule coil diameter resulting in platelet 
sphering in a manner similar to the initial events 
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seen in aggregating platelets (White 1968d), (2) 
simultaneous extension of the two ends of the 
mi crotubul ar coil into pseudopods as the dendri-
t ic platelet develops, (3) a phase of microtubule 
depolymerization in the dendritic platelet as 
cytosol calcium levels rise and (4) reformation 
of microtubules within the cytoplasm of the 
spreading platelet as gently curving structures 
oriented circumferentially both around the 
central granul omere and throughout the spreading 
cytoplasm. 
Disorders of Platelet Function 
This review will limit its discussion to 
three congenital bleeding disorders chosen 
because they represent specific defects in the 
membrane related functions, aggregation and adhe-
sion, and are therefore amenable to SEM study. 
Indeed, three dimensional structural studies, 
either SEM or whole mount TEM adhesion assays, of 
these disorders have contributed significantly 
more information relative to functional capacity 
than has conventional TEM of sectioned platelets. 
For an in-depth review of the literature on 
the historic, physiologic, and biochemical 
aspects of these disorders the reader is referred 
to several excellent reviews (Lusher and Barnhart 
1977, Bloom 1980, Weiss 1980, Barnhart and Lusher 
1981, Zimmerman and Ruggeri 1982). 
Von Willebrand's Disease (VWD): 
In 1926 von Willebrand described 23 members 
of a family with moderately severe clinical 
bleeding, prolonged bleeding times and an autoso-
ma l pattern of inheritance. Al most 30 yea rs 
later it was established that an abnormality of 
Factor VIII was present in this disorder when 
Alexander and Goldstein (1953) and later Juergens 
et al. (1957) reported a deficiency of Factor 
VIII procoagulant activity. As the biochemical 
and functional characteristics of the Factor VIII 
molecule have been elucidated, it has become 
apparent that patients with VWD may express defi-
ciencies in a variety of Factor VIII related 
functions. In 1971 Zimmerman et al. demonstrated 
that severe VWD patients were often deficient in 
both Factor VIII procoagulant activity and Factor 
vTTT related antigen (an antigen identified by a 
rabbit antibody raised against human Factor VIII) 
in contrast to hemophiliacs who lack procoagulant 
activity but possess normal amounts of Factor 
VIII related antigen. With the discovery of the 
ability of the antibiotic ristocetin to aggregate 
platelets in platelet-rich plasma from normal 
individuals but not from von Willebrand's 
patients, a biologic assay was developed for 
quantitating the plasma activity missing in VWD 
patients (Howard and Firkin 1971). This missing 
plasma factor in VWD is called von Willebrand 
factor while ristocetin cofactor activity refers 
to one functional attribute of von Willebrand 
factor, i.e. that measured in the ristocetin 
aggregation assay. In addition to support of 
ristocetin induced platelet aggregation, von 
Willebrand factor is required for adhesion of 
platelets to subendothelium (Tschopp et al. 
1974), retention of platelets on glass bead 
filters (Salzman 1963, Hattori et al. 1974c), and 
maintenance of a normal bleeding time in vivo. 
J. C. Mattson 
Defective adhesion to subendothelium has been 
demonstrated on rabbit aorta (Tschopp et al • 
1974), human umbi 1 ical vein (Lusher and Barnhart 
1977, Barnhart 1978, Barnhart et al. 1981), and 
human renal artery (Sakariassen et al. 1979). 
The defect in adhesion to rabbit aortic suben-
dothelium in VWD as demonstrated in an annular 
perfusion chamber is shear rate dependent (Weiss 
et al. 1978). The requirement for von Wi 11 ebrand 
factor in normal adhesion of platelets in unan-
ticoagulated blood to subendothelium is greatest 
at shear rates of 2600-3300 sec-1, within the 
range of those shear rates found in the micro-
vasculature (Weiss et al. 1978, Baumgartner et 
al. 1977). Baumgartner et al. (1980) have repro-
duced the adhesion defect of von Willebrand 
disease using antibodies to human factor VIII/van 
Willebrand factor. 
In their recent review, Zimmerman and Ruggeri 
(1982) summarize the evidence that Factor VIII is 
a molecular complex between the small procoagu-
lant molecule and the high molecular weight poly-
meric von Willebrand factor molecule, and that 
the von Willehrand factor activity of the Factor 
VIII complex is dependent on the presence of high 
molecular weight multimers (Ruggeri and Zimmerman 
1980, 1981). 
Classification of subtypes of VWD is based on 
differentiation of abnormalities of von 
Willebrand factor in plasma and platelets as well 
as on identification of variations in the mode of 
genetic transmission. The more common types of 
VWD (Types I, !IA, and IIB) show an autosomal 
dominant inheritance. Type I VWD, the most com-
mon subtype, is the result of a quantitative 
defect in the amount of von Willebrand factor 
present in plasma and is secondary to an absolute 
decrease in the amount of immunologically detec-
table factor VIII antigen. Multimer formation is 
normal. Because the absolute quantity of antigen 
is decreased, there is a proportional decrease in 
ristocetin cofactor activity and in the amount of 
factor VIII procoagulant activity. The latter is 
presumably secondary to lack of available von 
Willebrand factor for complexing and carrying the 
procoagulant molecule. Platelet von Willebrand 
factor is normal in quantity and multimer for-
mation (Ruggeri et al. 1978, Zimmerman and 
Ruggeri 1982). Type II VWD is characterized by 
an absence of large multimers of von Willebrand 
factor in plasma. In type !IA large multimers 
are absent from both plasma and platelets 
(Ruggeri and Zimmerman 1981, Zimmerman and 
Ruggeri 1982) and this absence is thought to 
reflect a defect in multimer assembly (Zimmerman 
and Ruggeri 1982). In type IIB , high molecular 
weight multimers are absent from plasma but pre-
sent in platelets (Ruggeri and Zimmerman 1980, 
1981). The von Will ebrand factor of type I IB is 
hyperresponsive to ristocetin leading to the 
hypothesis that the decrease in plasma multimers 
is secondary to increased binding of an abnor-
mally avid von Willebrand factor to platelets and 
tissue sites (Zimmerman and Ruggeri 1982). Type 
III VWD is the rarest type. This group contains 
the autosomal recessive forms of VWD. Affected 
individuals are severe bleeders and von 
Willebrand factor levels · in homozygotes and 
double heterozygotes may be undetectable in 
plasma, platelets, or endothelial cells, 
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suggesting a defect in synthesis or degradation 
within the cell of origin prior to release. 
"Pseudo" von Willebrand's disease has been 
recently described (Gralnick et al. 1981, Weiss 
et al. 1982). In this disorder, which resembles 
type IIB VWD, a platelet abnormality is respon-
sible for enhanced von Willebrand factor-platelet 
interaction following ristocetin stimulation. 
The abnormal platelets bind normal von Willebrand 
factor at lower concentrations of ristocetin than 
required to initiate von Willebrand factor 
binding to normal platelets. In one instance, 
von Willebrand factor induced platelet aggrega-
tion without ristocetin. The absence of large 
multimers in the plasma but not in the platelets 
in this disorder is probably due to enhanced 
removal by binding to platelets (Zimmerman and 
Ruggeri 1982). 
Conventional ultrastructural studies on 
ultrathin sections have not revealed any 
diagnostic morphologic alterations in VWD plate-
lets. While several authors (Schulz et al. 1958 , 
Jean et al. 1963, Marx and Jean 1964, Boisseau et 
al. 1976) have described abnormal drumstick gra-
nules in platelets of patients with von 
Willebrand's disease, Hovig (1968) and Lusher and 
Barnhart (1977), in their reviews of platelet 
morphology in disease, point out that this 
ultrastructural finding has been observed in 
other pathologic conditions (Jean et al. 1963, 
Marx and Jean 1964, Seip and Kjaerheim 1965) and 
in normal dog and human platelets (Hovig 1968). 
Lusher and Barnhart (1977) suggest that morpho-
metric analysis would provide quantitative data 
on the frequency of these granules in VWD vs. 
normal platelets. Platelets from swine with VWD 
show no abnormalities by SEM or TEM; in addition, 
they are capable of normal uptake of latex par-
ticles (Lewis and Bowie 1978). 
Scanning electron microscopy has yielded 
important data on the responsiveness of VWD pla-
telets to foreign and biologic surfaces. By SEM, 
reduced membrane responsiveness to formvar in a 
non-flow system has been observed in VWD plate-
lets (Lusher and Barnhart 1977, Barnhart 1978) 
although adhesion itself was described as fair in 
this test system. Altered surface responsiveness 
was reflected in failure of disc to sphere trans-
formation, defective pseudopod formation with a 
decrease in fully developed dendritic platelets, 
and increased numbers of abnorma 1 spread forms 
(Lusher and Barnhart 1977). 
In a similar manner, defective adhesion of 
VWD platelets to subendothelium has been studied 
ultrastructurally by SEM. Using an umbilical 
vein ex vivo perfusion model, Barnhart and her 
associates (Lusher and Barnhart 1977, Barnhart 
1978, Barnhart et al. 1981) demonstrated uni-
formly decreased adhesion of VWD platelets 
ranging from 7-51% of normal. While the majority 
of the VWD patients tested showed decreased 
spreading of platelets in addition to decreased 
adhesion, two patients demonstrated normal 
spreading over the exposed subendothelium. 
Bolhuis et al. (1981) reported that binding of 
von Willebrand factor to subendothelium precedes 
platelet adhesion and spreading. Sixma et al. 
(1982a), using human artery subendothelium in an 
annular perfusion chamber, have demonstrated a 
greater degree of impaired spreading in type !IA, 
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IIB, and III VWD as compared to type I. The dif-
ference in reactivity did not correlate with von 
Willebrand factor levels as reflected in the 
ristocetin cofactor activity assay. Turitto et 
al. (1983) eliminated the contribution of 
spreading to the adhesive process by chelating 
cations with EDTA and demonstrated a reduced 
attachment phase to chymotrypsin-treated suben-
dothelium in VWD as compared to normal. These 
findings suggest a role for high molecular weight 
multimers of von Willebrand factor in both 
attachment and spreading on subendothelium at 
appropriate shear rates. 
It appears well established that one can no 
longer envision adhesion as a simple process; 
adhesion clearly involves multiple complex steps 
including attachment, cellular activation, gra-
nule release and spreading (Allen et al. 1979, 
Turitto and Baumgartner 1982). v/hile our 
understanding of the role of von Willebrand fac-
tor in adhesion to subendothelium has grown enor-
mously in the past ten years, the factors which 
modulate the subsequent activation steps such as 
granule release and spreading are not yet worked 
out. Scanning electron microscopy is becoming an 
increasingly important tool in evaluating ~echa-
nisms which control platelet activation and 
spreading on surfaces. 
The Bernard Soulier S ndrome BSS 
The Bernard Soulier Syndrome BSS) is an auto-
somal recessive bleeding disorder characterized by 
variable degrees of thrombocytopenia, a prolonged 
bleeding time, and giant platelets on peripheral 
smear (Bernard and Soulier 1948). The bleeding 
time and clinical symptoms are out of proportion 
to the thrombocytopenia suggesting an intrinsic 
platelet defect (Caen et al. 1976). Additional 
laboratory characteristics include a normal clot 
retraction, defective prothrombin consumption, and 
diminished binding of coagulation factors V, VIII 
and XI to BSS platelets (Grottum and Solum 1969, 
Walsh et al. 1975). Aggregation of BSS platelets 
with ADP, epinephrine, and collagen is normal 
(Bithel l et al. 1972, Weiss et al. 1974, Caen et 
al. 1976). Indeed, the rate of ADP-induced aggre-
gation has been reported to be accelerated 
(Bithell et al. 1972). However, BSS platelets 
are not aggregated by ristocetin (Howard et al. 
1973a, Caen and Levy-Toledano 1973) (Figure 9A) or 
bovine factor VI I I (Weiss et al. 1974, Caen et al. 
1973, 1976). In contrast to von Willebrand's 
disease where defective ristocetin aggregation is 
corrected by replacing the missing von Willebrand 
factor, normal plasma containing von Willebrand 
factor does not correct the defective ristocetin 
aggregation of BSS (Caen and Levy-Toledano 1973, 
Howard et al. 1973b, Firkin et al. 1974). Based 
on these observations, it has been suggested that 
a membrane receptor for the von Wille~rand factor 
might be missing in BSS platelets. Grottum and 
Solum (1969) were the first to describe a platelet 
membrane defect in BSS when they demonstrated 
altered electrophoretic mobility and decreased 
membrane sialic acid content. The decreased 
sialic acid may be responsible for the shortened 
survival of BSS platelets (S Murphy 1972). Nurden 
and Caen (1975) extended these observations 
demonstrating deficient PAS staining of the gly-
coprotein I complex on SOS-PAGE gels of isolated 
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BSS platelet membranes. Nachman et al. (1977) 
suggested that glycoprotei n I (GP I) comple x 
mediates ristocetin aggregation. Nurden and Caen 
(1976, 1977), George et al. (1981), and Jamieson 
et al. (1979a) subsequently confirmed the defect 
in GP I complex in BSS platelets. The resolution 
of GP I com pl ex into its component glycoprotei ns by 
two dimensional gel electrophoresis (Nurden et al. 
1981, Peterson 1982) has allowed specific iden-
tification of GP Ib(Mr 139,000. pl 6.36) as the 
missing membrane component of BSS platelets. 
Glycocalycin (GP Is),a macropolypeptide associated 
with the GP I complex, has also been reported 
absent from BSS platelets (Jamieson et al. 1979b). 
Thus, a relationship between glycocalycin and the 
missing GP lb has been suggested (Hagen et al. 
1980). An antibody isolated from a transfused BSS 
patient inhibited ristocetin and bovine factor 
VIII aggregation of normal platelets as well as 
platelet adhesion to subendothelium (Tobelem et 
al. 1976). In addition, immunoprecipitation of 
platelet membrane proteins with this antibody 
brought down a 155,000 molecular weight component 
(Degos et al. 1977) providing further evidence 
that the membrane glycoproteinGP Ibmissing in BSS 
is required for von Willebrand factor mediated 
functions. 
While reports on the BSS platelet response to 
thrombin have been inconsistent, at least two 
laboratories (Ganguly 1977, Jamieson and Okumura 
1978) have demonstrated reduced numbers of throm-
bin binding sites and defective thrombin aggrega-
tion. Okumura et al. (1978) postulate that 
thrombin binds to a specific sequence in GP Is. 
Recently Nurden and Dupuis (1981) have reported 
the absence of a band corresponding to GP V. This 
required labelling techniques that were more sen-
sitive than those previously used to det ect GP I 
abnormalities. The lack of GP Vmay be responsible 
for the altered response to thrombin reported in 
some BSS patients as this glycoprotein is a 
substrate for thrombin. Clementson et al. (1982) 
have confirmed the absence of GP lb and GP V and 
have in addition demonstrated a deficiency of a 
low molecular weight glycoprotein, GP 17. 
Kunicki and Aster (1978) using a 51cr-lysis 
assay found that BSS platelets were not destroyed 
by quinine/quinidine dependent antibodies, and 
postulated that the receptor for these drug-
antibody complexes is deleted in BSS platelets. 
Van Leeuwen et al. (1982) using a platelet suspen-
sion immunofluorescence test demonstrated that 
drug induced antibodies require the Fe portion of 
the molecule to bind to platelets. They further 
showed that although these antigen-antibody 
complexes didn't produce lysis of BSS platelets, 
some of the antibodies did bind to BSS platelets 
while others didn't. This suggests that the Fe 
receptor for drug dependent antibodies is not 
necessarily absent in BSS platelets but may be 
altered in such a way as to prevent subsequent 
lysi s. 
The major functional abnormality in BSS is a 
defect in adhesion. Adhesion to rabbit suben-
dothelium is defective in both VWD (Tschopp et al. 
1974) and BSS (Weiss et al. 1973, 1978, Caen et 
al. 1976); Weiss et al. (1974, 1978) propose that 
the initial contact or attachment phase of adhe-
sion is defective in BSS. Zucker et al. (1977) 
and Moake et al. (1980) have demonstrated defec-
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Figure 9 A-D. Bernard Soulier Syndrome (BSS). A: 
Typical aggregation patterns. B: TEM ofsec-
tioned BSS platelets. C: SEM of 
EDTA-anticoagulated BSS platelets in suspension. 
D: SEM of adherent spread platelets from BSS 
hetero zygote on carbon-formvar surface; contact 
time 60 min. Aggregation curves in A demonstrate 
characteristic isolated absence of ristocetin 
aggregation. By conventional TEM (B) of sectioned 
BSS platelets, the only abnormality noted con-
sistently is the presence of large platelets with 
a corresponding increase in normal appearing gra-
nules. By SEM, EDTA-anticoagulated BSS platelets 
in suspe nsion (C) are enlarged as compared to nor-
mal platelets (insert). Note that EDTA induces 
sphering of both BSS and normal platelets. SEM of 
adherent and spreading platelets from BSS hetero-
zygote (the mother of 2 affected siblings) shows 
the giant size of occasional platelets 
interspersed among normal sized platelets. The 
small tear in the membrane near the granulomere is 
an artefact. Eleven percent of this BSS 
heterozygote's platelets were enlarged (>3.5 µm) 
by light microscopy. In addition, 10% of her 
spread forms were large (>12.5 µm). Bars= 1 
micrometer. 
tive binding of radiolabelled van Willebrand fac-
tor to BSS platelets. These data suggest that, 
under the appropriate flow conditions, adhesion of 
platelets to subendothelial structures is mediated 
by van Willebrand factor via membrane glycoprotein 
I b/1 s. 
Morphologic studies are of particular interest 
in BSS, since giant platelets on smear are a 
diagnostic feature of the disorder (Figure 9A-D). 
Mean platelet diameters as measured on peripheral 
smears demonstrate consistently enlarged platelets 
in several reported kindred: 3.2-3.4 µm 
(N=l.83+0.16) (Weiss et al. 1974), 3.09-4.44 µm 
(N=2.13+0.02) (George et al. 1981) and 3.5-3.7 µm 
(N=l.5-2.4) (Bithell et al. 1972). 
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In contrast, Frojmovic et al. (1977, 1978) 
have measured BSS discoid platelets and found them 
to be of near normal size. These authors found 
that induction of sphering produced BSS platelets 
that were disproportionately larger than normal 
sphered platelets (Frojmovic and Milton 1982) 
(Figure 9C). They cone l uded that a hyper-
vol umet ri c shape change occurs following stimula-
tion and that the giant appearance of BSS 
platelets in smears reflects abnormal membrane 
behavior during preparation of blood films 
(Frojmovic and Milton 1982). Evagination of an 
excessive internal membrane system has been 
suggested as a mechanism. Lusher and Barnhart 
(1977), however, found markedly enlarged BSS pla-
telets by TEM, and we have made similar obser-
vations on BSS platelets in directly fixed buffy 
coats (unpublished observations). Other evidence 
of altered membrane reactivity has been reported 
by Bithell et al. (1972) and Walsh et al. (1975) 
who demonstrated absent ADP-induced shape change 
in some of their BSS patients; this finding has 
not been confirmed in other affected kindred (Caen 
et al. 1973, Howard et al. 1973a). However, Caen 
et al. (1973) demonstrated that shape change takes 
longer to occur in BSS platelets which may explain 
the divergent observations on its presence by 
other investigators. 
Ultrastructural studies have described a 
variety of inconstant changes including disorga-
nized microtubules, granule deficiencies, promi-
nence of the OCS and DTS and increased vacuoles. 
Some platelets have been described as having a 
Swiss cheese appearance. In general, however, 
there are no characteristic ultrastructural 
features of the BSS platelet revealed by 
transmission electron microscopy other than the 
large size and a proportional increase in granules 
(White 1982, Maldonado et al. 1975, Mattson et al. 
1983) (Figure 9B). Chevalier et al. (1979) have 
demonstrated an abnormality in distribution of 
membrane associated particles (MAPS) as visualized 
in replicas of freeze fractured platelets. Rather 
than an equal and random distribution of MAPS on 
both exoplasmic (E) and protoplasmic (P) faces of 
the bil i pid membrane as seen in the normal, the 
BSS platelet had a greater concentration of par-
ticles on the protoplasmic face. We have recently 
reported that BSS platelets in native plasma are 
normally reactive to a formvar surface in a non-
flow system, demonstrating a rate of spreading 
comparable to or slightly greater than that of 
controls (Ma'ttson et al. 1984). In addition fully 
spread platelets from both homozygotes and hetero-
zygotes demonstrated heterogeneity of size with 
giant spread forms representing 22-44% of homozy-
gote platelets and 0-10% of heterozygote platelets 
(Figure 9D). Despite the abnormal size of a large 
percentage of BSS spread platelets, cytoskeletal 
architecture in both large and normal sized BSS 
platelets, as revealed by detergent extraction of 
whole mounts for TEM, was identical to normal-
sized control platelets. 
Glanzmann's Thrombasthenia (GT): 
Thrombasthenia is a rare disorder of platelet 
function first described by Glanzmann in 1918. It 
now appears that the original patients were a 
heterogeneous group who had in common normal or 
near normal platelet counts but defective clot 
retraction. Naegeli (1931) and Fonio and 
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Schwendener (1942) demonstrated that a prolonged 
bleeding time and isolated rather than aggregated 
platelets on peripheral smear were further charac-
teristics of this disorder. The main functional 
defect is an impairment of platelet aggregation 
(~/eiss 1975). Primary wave aggregation is absent 
in response to ADP, epinephrine, collagen, seroto-
nin, and noradrenalin (Hardi sty et al. 1964, Caen 
et al. 1966, 1972, Lusher et al. 1977) (Figure 
lOA). 
Early studies on the pathophysiology of 
Glanzmann's thrombasthenia (GT) implicated defi-
ciencies in various platelet enzymes (Gross 1961, 
Karpatkin and Weiss 1972, Moser et al. 1968) but 
consistent abnormalities have not been reported. 
Marcus and Zucker-Franklin (1964) and Caen et al. 
(1966) independently suggested that a primary 
membrane abnormality was responsible for the 
aggregation defect seen in these patients. 
However, direct evidence for such a defect was not 
found until the seventies when a decrease or 
absence of the externally exposed membrane gly-
coprotein complex GP IIb-IIIa was described by 
Nurden and Caen (1974) and confirmed by Phillips 
et al. ( 1975, 1977) and Peterson and 11ehri ng 
( 1981). It has been demonstrated that thromb-
asthenic platelets frequently lack fibrinogen 
(Caen et al. 1966, Nachman 1966, Nachman and 
Marcus 1968) and fail to bind fibrinogen normally 
following stimulation by ADP (Pfueller and Firkin 
1978, Bennett and Vilaire 1979), suggesting that 
the fibrinogen receptor may be GP IIb-Illa. 
Complexing of GP!Ib-lllarequires calcium 
(Jennings and Phillips 1982, Pidard et al. 1982). 
McEver et al. (1983), using a monoclonal antibody 
with specificity for the !lb-Illa complex but not 
to either I lb or I I I a al one, have demonstrated 
equal antibody binding to resting and stimulated 
platelets. This suggests that !lb and IIIa do not 
exist as discrete and separate glycoproteins in 
the resting platelet membrane but are complexed in 
both the resting and stimulated platelet. The 
binding of fibrinogen mediates aggregation by a 
mechanism not as yet worked out although various 
possibilities including direct bridging of adja-
cent platelets by fibrinogen have been suggested. 
In addition to lack of fibrinogen, deficiency 
of alpha-actinin has been detected in GT patients 
(Gerrard et al. 1979) suggesting that the 
GP IIb-lIIa complex may be bound to the platelet 
cytoskeleton via this protein. In addition, the 
platelet antigen p1Al has been shown to be asso-
ciated with GP I Ila (Kunicki and Aster 1979) and 
patients with thrombasthenia have variable defi-
ciencies in p1Al (Kunicki and Aster 1978). De 
Gaetano et al. (1977) suggest from data on defec-
tive GT fibroblast retraction in culture that the 
abnormality in cellular binding of fibrin/ 
fibrinogen might not be limited to platelets and 
might be responsible for the defective late wound 
healing observed at the skin biopsy site in their 
donor GT patient. More recently normal monocyte 
membranes have been reported to contain GP 
IIb-l!Ia but no data on monocytes from GT patients 
was reported (Gogstad et al. 1983). No comparable 
defect in red cell glycoproteins has been detected 
(George et al. 1980). 
Glanzmann's thrombasthenia has been recognized 
in both sexes. Based on a lack of significant 
clinical symptoms in parents of affected indivi-
duals and the frequency of consanguinity in some 
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Figure 10 A-E. Glanzmann's thrombasthenia ill..h_ 
A: aggregation patterns. Band C: Transmission 
electron micrographs of resting and ADP stimulated 
GT platelets respectively. D: Scanning electron 
micrograph of adherent GT platelets on a carbon-
formvar surface; contact time 60 min. E: TEM of 
whole mount preparation of adherent GT platelets 
on carbon-formvar; contact time 60 min. In A the 
characteristic absence of aggregation in response 
to ADP, collagen, and epinephrine is seen. TEM of 
unstimulated GT platelets show no abnormalities 
(B). ADP stimulated GT platelets (C) are able to 
undergo shape change (sphering and centralization 
of granules) in response to 2 x 10-6 M ADP despite 
inability to aggregate. In contrast, GT platelets 
do not spread normally on a carbon-formvar surface 
(D and E). By SEM (D) and TEM (E), pseudopod for-
mation is absent or abortive and spreading is not 
seen. Bars = 1 micrometer. 
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of the described affected families, an autosomal 
recessive inheritance has been proposed (Caen et 
a 1. 1966). 
Bleeding, which varies in severity and can be 
life threatening, usually begins in early life but 
tends to decrease with age. The bleeding is 
characterized by mucosal and cutaneous purpura. 
The diagnostic laboratory features are a normal 
platelet count, prolonged bleeding time, dimi-
Use of SEM to Study Platelets 
nished or absent clot retraction and markedly 
diminished primary wave aggregation (Weiss 1975). 
Regardless of the method used, aggregation by ADP, 
epinephrine, serotonin (5-hydroxytryptamine), 
thrombin, and collagen is defective (Hardisty et 
al. 1964, Caen et al. 1966, 1970, 1972, Zucker et 
al. 1966, Cronberg et al. 1967, 1971). 
Thrombasthenic platelets aggregate in response to 
ristocetin in the presence of adequate factor VIII 
and to bovine fibrinogen (presumably due to the 
presence of bovine factor VIII) (Weiss 1975). 
Despite the inability to aggregate to all con-
centrations of ADP, thrombasthenic platelet 
membranes bear the ADP receptor (Bennett et al. 
1977) and demonstrate the ability to change shape 
following ADP stimulation (Zucker et al. 1966) 
(Figure lOC). Platelet release of ADP and PF4 are 
normal in response to collagen and thrombin 
(Kubisz et al. 1971, Caen 1972, Weiss and Rogers 
1973) but defective in the presence of ADP and 
epinephrine (Zucker et al. 1966, Caen et al. 1970, 
Cronberg et al . 1967). Wh i 1 e the aggregation 
defect appears well established, thrombasthenic 
platelets show variable defects in adhesion 
depending on the method and substrate tested. In 
vivo platelet adhesion, as measured by the method 
of Borchgrevi nk, is decreased (Borchgrevi nk 1961). 
Adhesion of thranbasthenic platelets to collagen 
has been reported as normal or near normal 
(Balleisen et al. 1977, Caen 1972, Zucker et al. 
1966) in some patients while defective interaction 
with collagen has been reported in other GT 
patients (Balleisen et al. 1977), with abnormal 
adhesion, defective pseudopod formation and absent 
spreading. Adhesion of GT platelets to suben-
dothelium and to chymotrypsin-exposed collagen 
fibrils is reduced liith absent platelet thrombi. 
Examination of adherent GT platelets by TEM 
demonstrated centralization of filaments, 
sphering, and decrease in granules suggesting that 
the contractile wave and release had occurred 
(Baumgartner et al. 1977). Platelet retention in 
a glass bead column is often markedly reduced 
(Salzman 1963); this has been attributed to the 
defect in aggregation since this test assesses 
both adhesion and aggregation. Platelet adhesion 
and spreading on a glass slide is absent or 
markedly reduced (Caen et al. 1966, 1972) as is 
adhesion to formvar in a non-flow system (Lusher 
and Barnhart 1977, Lusher et al. 1977). 
By light microscopy of stained smears the only 
defect appreciated is the lack of aggregation; no 
abnormality has been noted in individual plate-
lets. Electron microscopy of thin sectioned 
unstimulated GT platelets reveals essentially nor-
mal ultrastructure (Lusher and Barnhart 1977, 
Boisseau et al. 1976, Caen et al. 1966) (Figure 
lOB). In ADP stimulated GT platelets, a contrac-
tile wave can be appreciated as granules and 
microfilaments condense centrally. In contrast to 
normal ADP aggregates in which each compact 
granule/microfilament mass is oriented toward the 
center of the aggregate, in GT platelets the 
contractile wave is oriented to the center of each 
unaggregated platelet (Gerrard et al. 1979) 
(Figure lOC). 
Morphologic abnormalities in adhering GT pla-
telets have been described using a variety of 
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techniques. Rosenstein et al. (1981) have 
demonstrated defective spreading on a siliconized 
glass slide by DIC microscopy. Failure to interact 
with fibrin strands was also noted. Lusher and 
colleagues (Lusher and Barnhart 1977, Lusher et 
al. 1977) using contact activation and adhesion to 
formvar to evaluate platelet membrane reactivity 
and viewing the reacting platelets by either SEM 
or TEM have demonstrated a decrease in adhesion 
after 8 minutes of exposure to formvar. Pseudopod 
formation was abnormal and subsequent spreading 
defective (Lusher and Barnhart 1977, Lusher et al. 
1977). Adherent platelets demonstrated sphering 
with convoluted surface contours. In a similar 
test system using an extended period of exposure 
to the formvar surface, we have also observed 
decreased numbers of attached platelets, defective 
pseudopod formation and total absence of spread 
forms even after 60 minutes of contact (Figure 
lOD, E). 
The defective adhesion and spreading on 
foreign surfaces demonstrated in GT platelets in 
non-flow systems suggest a role for the missing 
GP IIb-IIIa in platelet attachment and spreading. 
This possibility is further supported by obser-
vations that fibrinogen coating of substrates 
enhances platelet adherence (Packham et al. 1969, 
Zucker and Vroman 1969). Since GP IIb-IIIa is the 
putative fibrinogen receptor, platelet adhesion to 
foreign surfaces may be mediated at least in part 
through GP IIb-IIIa interaction with a fibrinogen 
coat. It must also be considered that the defect 
in spreading may not be directly related to the 
missing membrane glycoproteins but may be the 
result of defective adhesion-induced release of 
cofactors required for spreading. 
New Directions 
The importance of pl a tel et membrane receptors 
in adhesion and aggregation reactions both as 
binding sites for agonists that initiate the pla-
telet response and as final effector sites for 
binding to molecules that directly mediate adhe-
sion and/ or aggregation cannot be denied. SEM has 
played a major role in increasing our understand-
ing of membrane events during platelet activation. 
Use of specific labeling techniques with visible 
probes has proved an exciting recent development 
for study of receptor mobility, orientation, and 
relationship to localized subcellular structures 
such as membrane systems (OCS, DTS), and cytoske-
letal components. Nurden et al. (1980) used gold 
spheres bound to lectins to demonstrate lectin 
binding sites on washed, fixed, discoid (resting) 
platelets. Wheat germ agglutinin (WGA) receptors 
were seen scattered over the platelet surface and 
in the rare pseudopod present. Concanavalin A 
(conA) binding could be seen by TEM but not SEM. 
The difference in SEM/TEM visualization is 
unexplained; the authors suggest that perhaps conA 
receptors in the resting platelet are in crygtic 
sites inaccessible to Au particles of 12-50 A 
size. SEM showed an even distribution of bound 
WGA, and by double labeling TEM studies with gold 
particles of two different sizes, WGA and conA 
distributions were seen to be separate. These 
immunolabelling studies correlate with biochemical 
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data demonstrating that conA binds to a major 
membrane GP of 100,000 molecular weight (Nachman 
et al. 1973) while WGA binds to 2 different gly-
coproteins of molecular weight s 150,000 and 
210,000 respectively (Nachman et al. 1977). 
While this study specifically restricted 
itself to the unstimulated platelet, other surface 
labelling studies have examined receptor mobility 
following stimulation. Furlan et al. (1981) exa-
mined the distribution of colloidal gold complexed 
to low molecular weight oligomers of bovine factor 
VIII on platelet surfaces using both SEM and TEM. 
On unfixed platelets the gold-factor VIII probe 
was capable of inducing aggregation, and the sti-
mulated platelets showed random distribution of 
the probe on the surface with greatest binding to 
platelets that appeared stimulated or damaged by 
TEM. If platelets were fixed first, factor VIII 
binding appeared most concentrated on pseudopods. 
This work suggests receptor site redistribution 
with stimulation. In a slightly different 
approach, Polley et al. (1981) have used immu-
noelectron microscopy with ferritin and hemocyanin 
labels on intact platelets followed by lysis and 
examination of resultant isolated membranes by TEM 
to examine membrane glycoprotein distribution in 
unstimulated and thrombin-stimulated platelets. 
They found random distribution of both GP !lb and 
GP Illa in unstimulated platelets while GP lb was 
present in small clusters. Thrombin stimulation 
produced large mixed clumps of GP Ilb and GP Illa 
and separate large clusters of GP lb. 
Barnhart and Robinson (1975) used latex probes 
couple d with antibodies to platelet factor 3 (PF3) 
and fibrinogen to demonstrate their distribution 
before and after thrombin stimulation. By this 
technique thrombin activated platelets 
demonstrated significantly more PF3 in the 
membrane surface than unactivated platelets. 
Fibrinogen was slightly increased on the platelet 
surface after thrombin stimulation but more impor-
tant was the observation that fibrinogen was con-
centrated at the platelet periphery and along 
pseudopods rather than randomly dispersed. In more 
recent studies, using an antibody to factor VIII 
antigen covalently linked to a latex probe, Lusher 
and Barnhart (1977) demonstrated by SEM that les s 
binding occurs to VWD platelets than to normal 
platelets, suggesting a decrease in surface-bound 
factor VIII on VWD platelets. 
Albrecht and Lewis (1982) presented work on 
mapping contact activation-induced changes in 
membrane receptors for fibrinogen, fibronectin and 
thrombospondin using gold-protein beads and gold 
immunobeads. 
This new approach will allow investigators to 
use SEM to identify functional defects in recep-
tors in patients who have antigenically normal 
amounts of receptor present. With the development 
of monoclonal antibodies to mediator proteins such 
as VWF and fibronectin and to specific platelet 
membrane components, the future will surely see 
the "mapping" of platelet functional sites. 
Conclusion 
While the direct examination of platelets by 
SEM and TEM may be helpful in determining if pla-
telets have been activated in vivo, the infor-
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mation der ived is limited and does not allow one 
to distinguish etiologies. A more important 
application of correlative SEM/TEM in the diagno-
sis of platelet dysfunction is the observation of 
platelet reactivity to aggregating agents or acti-
vating surfaces. Under these circumstances SEM 
and TEM can serve as important adjuncts to the 
clinical assessment of platelet function. It must 
be emphasized that because three dimensional 
changes in form may be the result of severa l dif-
ferent internal events, maximum information is 
obtained when SEM and TEM are used together. 
Using correlative SEM/TEM, the ability of plate-
lets to undergo the normal physiologic responses 
of adhesion, spreading, pseudopod formation, gra-
nule release, aggregation, and internal contrac-
tion can be assessed ultrastructurally. With the 
use of visible probes, future mapping of membrane 
receptors for agonists and inhibitors and membrane 
sites mediating adhesion and aggregation will 
undoubtedly be added to our diagnostic capabili-
ties and will allow more precise documentation of 
those platelet disorders associated with acquirerl 
and inherited membrane abnormalities. 
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Use of SEM to Study Platelets 
Discussion with Reviewers 
D.A. Walz: One of the major unanswered questions 
in platelet release reactions is the process of 
degranulation. Have you any SEM or TEM data which 
readily supports one type of mechanism, say gra-
nule membrane fusion, over alternative hypotheses, 
such as granule membrane disintegration or 
release? 
Author: To my knowledge, there is no morphologic 
data in the literature which definitively 
distinguishes between platelet granule release by 
a mechanism of membrane fusion versus a mechanism 
of membrane dissolution. However, it seems 
likely, drawing parallels from other secretory 
cells, that the process probab ly includes fusion 
of granule membranes with membranes of the open 
canalicular system (OCS) with subsequent rupture 
of the fused membranes and release of granule con-
tents into the OCS. In support of this thesis, 
White (1973) has demonstrated granule contents 
within the OCS following poly-L-lysine stimulation 
of platelets. 
D.A. Walz: You have made reference to the process 
of contractile wave observations (Figure 4). 
Could you elaborate on its definition and 
,description; is it a physical process observed by 
SEM? The tenn implies one of continual motion, 
particularly directional motion, and I am unclear 
regarding its relationship to SEM. 
Author: Morphologic data supporting the concept 
oTac:ontractile wave comes primarily from TEM 
observations of sectioned unstimulated and stimu-
lated platelets. Stimulus-induced shape change is 
accompanied by the appearance of a dense central 
matrix of contractile filaments. When aggregates 
are formed, these masses of filaments are oriented 
toward the center of the aggregate rather than the 
center of each participating platelet, but when 
aggregation is blocked, as it is in Glanzmann's 
thrombasthenia, the filament matrix is found in 
the center of each individual platelet. 
Accompanying this condensation of cytoskeletal 
filaments is the migration of platelet granules to 
the cell center. It is implied that the forces 
for granule movement and their subsequent secre-
tion is generated by the contraction of actomyosin 
within the cytoskeleton. Further morphologic data 
for contraction of the cytoskeleton comes from 
studies of isolated cytoskeletons from thrombin-
treated platelets. Jennings et al. (1981) 
observed that the shell of actin filaments, which 
forms around the centralized granules in thrombin 
stimulated platelets, contracts from a diameter of 
2.1 µm to 1.5 µm. 
D.A. l·lalz: You make reference to seeing similar 
structures by SEM and TEM. Is it possible to go 
from one procedure to the other on the same speci-
men or is the reference more general in that it 
refers to similar regions in different platelets? 
Author: It is possible to examine whol e mount 
preparations of adherent platelets first by TEM 
and then, after appropriate coating with a hi ghly 
conductive element such as gold, to examine the 
identical eel ls by SEM. The use of "finder grids" 
simplifies identification of specific cells. 
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However, in the correlative SEM/TEM studies 
illustrated in this review which demonstrate the 
morphologic changes acompanying platelet 
aggregation (Figures 4 and 5), it l'las necessary to 
examine separate aliquots from the same aggrego-
meter sample. This was necessary because the TEM 
samples were embedded and sectioned, while the SEM 
samples were of whole cells. Our method of pre-
paring aliquots of the same sample for SEM and TEM 
have been previously published in detail (Mattson 
et al . 1977). 
D.A. Walz: One of the most exciting extensions of 
SEM is its application to platelet mapping. Do you 
envision these procedures as ult imately being 
capable of resolving specific receptor sites, such 
as those for thrombin and collagen? 
Author: Absolutely. With the use of probes 
visible at the resolving power of SEM, such as 
colloidal gold, studies can be performed l'lith spe-
cific proteins such as collagen or thrombin 
directly bound to the probe and the pattern of 
attachment observed. Such studies have already 
been reported for fibrinogen, fibronectin and fac-
tor VIII (see text). Conversely, putative recep-
tors can be mapped using specific antibodies to 
individual membrane glycoproteins. This approach 
will be invaluable in the investigation of the 
mechanisms by which receptors modulating adhesion 
and aggregation become available after stimulation 
of the platelet by specific agonists. In the area 
of diagnostics, it will allow rapid identification 
of missing membrane receptors. 

